TRANSLATIONAL BIOINNOVATION · TAIWAN

Mitochondria. Telomeres. A path to translation.

Prof. Yu-Lin Yang connects mitochondrial and telomere research with regenerative medicine, natural bioactives and research partnerships.

EST.20+YEARS OF CONNECTED RESEARCH
Prof. Yu-Lin Yang, Ph.D.

Prof. Yu-Lin Yang, Ph.D.

Dean, College of Medical Technology · Professor of Medical Laboratory Science and Biotechnology

A translational scientist and academic leader connecting telomere biology, mitochondrial science, regenerative medicine and biomedical commercialization.

Current appointments

  • Dean, College of Medical Technology, Chung Hwa University of Medical Technology (since 2021)
  • Professor, Department of Medical Laboratory Science and Biotechnology / Graduate Institute of Biomedical Science (since 2008)
  • Joint Professor, Universitas Muhammadiyah Surabaya, Indonesia (since 2026)
  • Joint Professor, College of Life Sciences, Kaohsiung Medical University (from 2026)

Education & international training

B.S. in Medical Technology and M.S./Ph.D. in Medicine, Kaohsiung Medical University; first-ranked doctoral graduate and recipient of an outstanding dissertation award. Exchange scholar at the University of Queensland under a Taiwan–Australia bilateral program.

Selected leadership & honors

  • Former Vice President and Dean of Academic Affairs, Chung Hwa University of Medical Technology
  • Reviewer for national science, education, SBIR and innovation programs
  • National Teacher of the Year Award, Ministry of Education
  • International invention awards and long-term national research support

Research focus

  • Telomere biology & cellular aging
  • Mitochondrial bioenergetics
  • Stem-cell & regenerative medicine
  • Translational natural bioactives

Academic & innovation impact

~60SCI-indexed papers
34invention patent filings
20+years of connected research
2018National Teacher of the Year
01

What we do

Build evidence across mechanisms, cells, disease models and translational settings.

02

What we have

Longitudinal research platforms in NRF1, mitochondria, telomeres, MSCs and natural bioactives.

03

What we seek

Hospitals, international laboratories, CROs, manufacturers and venture partners.

04

How to collaborate

Joint R&D · validation · clinical translation · technology transfer · product development.

Start with the problem you want to solve.

Find the research capabilities and partner roles relevant to your next study.

Research you can build on.

Explore active research and established platforms, followed by emerging proposals. Each project shows its current stage and opportunities for collaboration.

Explore the orbit of questions, methods and translation.

Hover or click a galaxy. Lock-on focus reveals its research signal.

2026Active

Translational & Clinical Research

NRF1, Mitophagy & Lung-cancer Response

An active disease-model program examining how NRF1-linked mitochondrial quality control may shape lung-cancer treatment response.

2025–2026Active

Regenerative Medicine

NRF1, Telomere Regulation & Stem-cell Function

Mechanism-led research connecting NRF1, telomere maintenance and mitochondrial homeostasis with functional stem-cell outcomes.

2017–2026Active

Translational & Clinical Research

Mitochondrial Biology in Cancer Models

A sustained research portfolio using mitochondrial regulation and cellular stress biology to investigate cancer progression and treatment response.

2027Proposal

Regenerative Medicine

NRF × MSC Rejuvenation Platform

A translational program exploring how natural regenerative signaling may support measurable MSC quality and cellular resilience.

2026Proposal

Technology Commercialization

HerboChip Functional-guided Screening & Knowledge Transfer

A two-decade functional-guided discovery workflow is being organized into a reproducible, teachable and industry-auditable platform.

2026Proposal

Neuroscience & Healthy Aging

Mitochondrial Activation for Post-stroke Neural Repair

A proposed basic–clinical collaboration centered on mitochondrial dysfunction, oxidative stress and loss of neural plasticity after ischemic injury.

Follow the research through its published record.

49 public PubMed records are organized by research signal. Filter a direction, search a concept, then open the original article record.

6 of 49 records · each entry links to PubMed

2026

Cancer, Mitochondria & Cell Plasticity

NRF1 Activates the AMPK/SIRT1/PGC-1α/TFAM Axis to Suppress EMT and Tumor Progression in Lung Adenocarcinoma.

Cancer Genomics & Proteomics

Open in PubMed
2025

Cancer, Mitochondria & Cell Plasticity

Verbascoside Suppresses Epithelial-Mesenchymal Transition and Mitochondrial Biogenesis by Targeting Anti-senescence Signaling in Castration-resistant Prostate Cancer.

Cancer Genomics & Proteomics

Open in PubMed
2025

Cancer, Mitochondria & Cell Plasticity

SCAMP3 and EPS8 Cooperatively Regulate EGFR Signaling to Promote Enzalutamide Resistance and Metastatic Potential in Prostate Cancer.

Cancer Genomics & Proteomics

Open in PubMed
2025

Cancer, Mitochondria & Cell Plasticity

Rutin Suppresses EMT and Induces Mitochondrial Biogenesis via ER Stress-linked AMPK/SIRT1 Signaling in Prostate Cancer Cells.

Cancer Genomics & Proteomics

Open in PubMed
2023

Cancer, Mitochondria & Cell Plasticity

The Regulatory Role of Nuclear Respiratory Factor 1 in Bladder Cancer Cells.

Anticancer Research

Open in PubMed
2022

Cancer, Mitochondria & Cell Plasticity

Nuclear Respiratory Factor 1 Overexpression Inhibits Proliferation and Migration of PC3 Prostate Cancer Cells.

Cancer Genomics & Proteomics

Open in PubMed

A connected evidence stack.

01

Mitochondrial function

NRF1 signaling, biogenesis, membrane potential, energy metabolism and stress response.

02

Cellular aging

Telomere, autophagy, oxidative stress, senescence and functional cell-quality endpoints.

03

Functional discovery

Standardized natural materials, fractionation, target screening and orthogonal validation.

04

Translation

Hospital disease models, preclinical planning, IRB-aware protocols and industry validation.

Bring a question, material, model or market need.

We shape a bounded collaboration around the evidence needed for the next decision.

01Joint R&D02Independent validation03Clinical translation04Technology transfer05Product development06International consortium

Research, recognition and public stories.

Browse stories by event and year, with links to the original sources.

Explore by signal

Search Google for more
2026

Innovation & invention · Yam News

Gold Medal and Thailand Special Award at the 2026 JDIE Japan Design, Idea & Invention Expo

A cross-disciplinary team led by Prof. Yang was recognized for an NRF-enabled approach to increasing exosome secretion in stem-cell culture.

Read original coverage
2025

Innovation & invention · Chung Hwa University of Medical Technology

NRF Team Receives Gold at the 2025 Bangkok International Invention Awards

Institutional news documenting international recognition and a Taiwan invention patent for the NRF research team.

Read original coverage
2023

Innovation & invention · NextApple News

NRF Mitochondrial Activation Skin Technology Wins ITEX Gold

News coverage of an NRF-linked skin-repair technology developed with students and recognized among international invention entries.

Read original coverage
2018

Honors & recognition · Ministry of Education

National Teacher of the Year: Educational Leadership Profile

The Ministry of Education profile highlights educational philosophy, academic administration and contributions to student development.

Read original coverage
2017

International exchange · Fujian Health College

Invited Academic Exchange on Data-Informed University Management

A visiting exchange introduced university-management experience and explored future collaboration in education, curriculum development and research.

Read original coverage
2013

Innovation & invention · Ministry of Education

ITEX International Invention Exhibition Gold Medal

The Ministry of Education’s Teacher of the Year archive records this international invention exhibition recognition among Prof. Yang’s honors.

Read original coverage